Adjuvant endocrine treatment (goserelin vs tamoxifen) in pre-menopausal patients with operable node positive stage II breast cancer. A prospective randomized national multicenter study.

Söreide, J A; Varhaug, J E; Fjösne, H E; Erikstein, B; Jacobsen, A-B; Skovlund, E; Kvinnsland, S

Söreide, J A; Varhaug, J E; Fjösne, H E; Erikstein, B; Jacobsen, A-B; Skovlund, E; Kvinnsland, S.

Affiliation

Söreide JA; Department of Surgery, Rogaland Central Hospital, Stavanger, Norway. ja-sor@netpower.no

Eur J Surg Oncol ; 28(5): 505-10, 2002 Aug.

Article de En | MEDLINE | ID: mdl-12217302

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique / Goséréline / Antinéoplasiques hormonaux Type d'étude: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: Eur J Surg Oncol Sujet du journal: NEOPLASIAS Année: 2002 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links